Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Codiak Biosciences Inc (CDAK)

Codiak Biosciences Inc (CDAK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Codiak Biosciences Inc 35 CambridgePark Drive Suite 500 Cambridge MA 02140 USA

P: 617-949-4100

Description:

Codiak BioSciences Inc. is a clinical-stage biopharmaceutical company. It is focused on development of exosome-based therapeutics for spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease. Codiak BioSciences Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 402,628
Shares Outstanding, K 22,331
Annual Sales, $ 2,920 K
Annual Net Income, $ -91,670 K
Last Quarter Sales, $ 890 K
Last Quarter Net Income, $ -21,810 K
% of Insider Shareholders 6.62%
% of Institutional Shareholders 62.75%
Float, K 20,853
% Float 93.38%

Growth:

1-Year Return 57.92%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/05/21
Earnings Per Share ttm -15.47
EPS Growth vs. Prev Qtr -94.12%
EPS Growth vs. Prev Year -17.62%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CDAK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -54.33%
Profit Margin % -3,139.38
Net Margin % N/A
Debt/Equity 0.37
Price/Sales 133.76
Price/Cash Flow N/A
Price/Book 7.18
Book Value/Share 2.35
Interest Coverage -46.99
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar